• Affimed to Present at the Cowen and Company 38th Annual Health Care Conference MarketScreener Thu, 03 Jul 2025 06:45:59 GMT
• Affimed (NASDAQ:AFMD) Given Consensus Recommendation of “Hold” by Analysts Defense World Sun, 15 Jun 2025 07:00:00 GMT
• affimed receives nasdaq deficiency notice over low share price: retail’s in wait-and-wait mode MSN Thu, 12 Jun 2025 03:16:32 GMT
• affimed (afmd) expected to announce quarterly earnings on wednesday Defense World Wed, 04 Jun 2025 07:00:00 GMT
• northern trust corp takes $218,000 position in affimed (nasdaq:afmd) Defense World Tue, 03 Jun 2025 07:13:48 GMT
• affimed (nasdaq:afmd) receives consensus recommendation of “hold” from analysts Defense World Wed, 21 May 2025 05:44:31 GMT
• three new option listings and fifteen option delistings on may 20th TipRanks Tue, 20 May 2025 13:04:07 GMT
• Affimed’s ASCO ‘Hail Mary’ As Survival Chances Slim insights.citeline.com Tue, 20 May 2025 07:00:00 GMT
• biotech alert: searches spiking for these stocks today Yahoo Finance Tue, 20 May 2025 07:00:00 GMT
• new development for afmd options as may 20th approaches | afmd s GuruFocus Tue, 20 May 2025 07:00:00 GMT
• dow tumbles 200 points; zim integrated shipping services posts upbeat earnings Benzinga Mon, 19 May 2025 13:58:42 GMT
• affimed (nasdaq:afmd) earns sell rating from analysts at stocknews.com Defense World Mon, 19 May 2025 09:11:28 GMT
• Why Did Affimed Plunge 35.13%? Nasdaq Delisting, Insolvency Filing AInvest Mon, 19 May 2025 07:00:00 GMT
• affimed fy2025 eps estimate boosted by cantor fitzgerald Defense World Mon, 19 May 2025 07:00:00 GMT
• q1 earnings estimate for affimed issued by leerink partnrs Defense World Fri, 16 May 2025 07:00:00 GMT
• affimed (nasdaq:afmd) cut to “hold” at leerink partnrs Defense World Fri, 16 May 2025 07:00:00 GMT
• hc wainwright downgrades affimed (nasdaq:afmd) to neutral Defense World Fri, 16 May 2025 07:00:00 GMT
• hodgkin’s lymphoma pipeline appears robust with 15+ key pharma companies actively working in the therapeutics segment | delveinsig... The Globe and Mail Thu, 15 May 2025 07:00:00 GMT
• wells fargo & company reiterates equal weight rating for affimed (nasdaq:afmd) Defense World Thu, 15 May 2025 07:00:00 GMT
• leerink partners reiterates “market perform” rating for affimed (nasdaq:afmd) Defense World Thu, 15 May 2025 07:00:00 GMT
• affimed shares crash after filing for the opening of insolvency proceedings MSN Thu, 15 May 2025 05:24:45 GMT
• health care stocks face broad downturn as sector challenges mount Finimize Wed, 14 May 2025 19:35:21 GMT
• wells fargo downgrades affimed (afmd) with new price target | af GuruFocus Wed, 14 May 2025 07:45:46 GMT
• affimed (afmd) seeks insolvency proceedings amid financial strug GuruFocus Wed, 14 May 2025 07:06:05 GMT
• Bluebird extends deal deadline; Affimed files for insolvency BioPharma Dive Wed, 14 May 2025 07:00:00 GMT
• Affimed Stock to Be Delisted from Nasdaq, Trading Suspended May 20 Following Insolvency Stock Titan Wed, 14 May 2025 07:00:00 GMT
• Cantor Fitzgerald cuts Affimed stock rating on insolvency news Investing.com Wed, 14 May 2025 07:00:00 GMT
• Affimed shares to be delisted from Nasdaq after insolvency filing Investing.com Wed, 14 May 2025 07:00:00 GMT
• Immuno-oncology company Affimed to be delisted from Nasdaq after insolvency filing (AFMD:NASDAQ) Seeking Alpha Wed, 14 May 2025 07:00:00 GMT
• affimed (afmd) faces delisting from nasdaq | afmd stock news GuruFocus Wed, 14 May 2025 07:00:00 GMT
• hc wainwright downgrades affimed n.v to neutral from buy MarketScreener Wed, 14 May 2025 07:00:00 GMT
• affimed (afmd) downgraded to neutral by hc wainwright & co. | af GuruFocus Wed, 14 May 2025 07:00:00 GMT
• affimed (afmd) faces downgrade amid insolvency proceedings | afmd stock news GuruFocus Wed, 14 May 2025 07:00:00 GMT
• cantor fitzgerald downgrades affimed to neutral from overweight marketscreener.com Wed, 14 May 2025 07:00:00 GMT
• affimed’s insolvency proceedings and liquidity crisis lead to hold rating TipRanks Wed, 14 May 2025 07:00:00 GMT
• leerink cuts affimed stock target to $0.39, downgrades rating by investing.com Investing.com Canada Wed, 14 May 2025 06:59:44 GMT
• Health Care Stocks Face Broad Downturn As Sector Challenges Mount Finimize Tue, 13 May 2025 20:12:47 GMT
• affimed downgraded to equal weight at wells after insolvency filing TipRanks Tue, 13 May 2025 18:46:22 GMT
• afmd: leerink partners downgrades affimed with new price target GuruFocus Tue, 13 May 2025 16:05:40 GMT
• affimed announces filing for opeing of insolvency proceedings TipRanks Tue, 13 May 2025 14:37:49 GMT
• affimed shares crash after filing for the opening of insolvency proceedings MSN Tue, 13 May 2025 13:18:20 GMT
• affimed (afmd) seeks insolvency proceedings amid financial struggles | afmd stock news GuruFocus Tue, 13 May 2025 13:00:43 GMT
• Affimed’s Financial and Strategic Challenges Lead to Hold Rating Amid Funding and Regulatory Concerns TipRanks Tue, 13 May 2025 11:40:10 GMT
• Affimed Announces Filing for the Opening of Insolvency Proceedings GlobeNewswire Tue, 13 May 2025 07:00:00 GMT
• Affimed's Crossroads: Clinical Promise vs. Cash Crisis – A Biotech's Last Gambit? AInvest Tue, 13 May 2025 07:00:00 GMT
• Leerink cuts Affimed stock target to $0.39, downgrades rating Investing.com Tue, 13 May 2025 07:00:00 GMT
• afmd trading halted: awaiting important news | afmd stock news GuruFocus Tue, 13 May 2025 07:00:00 GMT
• affimed (afmd) downgraded as funding prospects dim | afmd stock news GuruFocus Tue, 13 May 2025 07:00:00 GMT
• affimed (afmd) files for insolvency amid financial challenges GuruFocus Tue, 13 May 2025 07:00:00 GMT
• wells fargo downgrades affimed (afmd) with new price target | afmd stock news GuruFocus Tue, 13 May 2025 07:00:00 GMT
• affimed shares down, halted in premarket on bankruptcy application MarketWatch Tue, 13 May 2025 07:00:00 GMT
• afmd stock downgraded as wells fargo slashes price target | afmd GuruFocus Tue, 13 May 2025 07:00:00 GMT
• affimed (afmd) faces downgrade amid insolvency proceedings | afmd stock news GuruFocus Tue, 13 May 2025 07:00:00 GMT
• leerink downgrades affimed to market perform from outperform marketscreener.com Tue, 13 May 2025 07:00:00 GMT
• wells fargo downgrades affimed to equalweight from overweight; shares plunge marketscreener.com Tue, 13 May 2025 07:00:00 GMT
• affimed (afmd) resumes trading, offering market opportunities | GuruFocus Tue, 13 May 2025 07:00:00 GMT
• this rapid7 analyst turns bearish; here are top 4 downgrades for tuesday Benzinga Tue, 13 May 2025 07:00:00 GMT
• this caterpillar analyst turns bullish; here are top 5 upgrades for tuesday Benzinga Tue, 13 May 2025 07:00:00 GMT
• immuno-oncology company affimed to be delisted from nasdaq after insolvency filing MSN Tue, 13 May 2025 07:00:00 GMT
• Affimed Shows Higher Exposure of AFM24 is Associated with GlobeNewswire Tue, 29 Apr 2025 07:00:00 GMT
• breakthrough: afm24 cancer drug achieves 33% response rate in lung cancer with new dosing strategy Stock Titan Tue, 29 Apr 2025 07:00:00 GMT
• affimed n.v. reports positive findings on afm24's exposure-outcome analysis in refractory non-small cell lung cancer patients Nasdaq Tue, 29 Apr 2025 07:00:00 GMT
• affimed (nasdaq:afmd) receives consensus rating of “moderate buy” from analysts Defense World Sat, 26 Apr 2025 07:00:00 GMT
• affimed (nasdaq:afmd) coverage initiated at stocknews.com Defense World Fri, 25 Apr 2025 07:00:00 GMT
• Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting GlobeNewswire Wed, 23 Apr 2025 07:00:00 GMT
• Affimed Secures Coveted Oral Presentation Slot at ASCO 2025: Phase 2 Lymphoma and Lung Cancer Data Stock Titan Wed, 23 Apr 2025 07:00:00 GMT
• affimed n.v. announces accepted abstracts for oral and poster presentations at asco 2025 annual meeting Quiver Quantitative Wed, 23 Apr 2025 07:00:00 GMT
• Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement GlobeNewswire Mon, 21 Apr 2025 07:00:00 GMT
• Affimed N.V. Receives Nasdaq Notification Regarding Minimum Bid Price Compliance Nasdaq Mon, 21 Apr 2025 07:00:00 GMT
• Affimed Gets 180-Day Nasdaq Grace Period After Stock Falls Below $1, Extension Possible Stock Titan Mon, 21 Apr 2025 07:00:00 GMT
• Affimed Receives Nasdaq Deficiency Notice Over Low Share Price: Retail’s In Wait-And-Wait Mode Stocktwits Mon, 21 Apr 2025 07:00:00 GMT
• affimed (afmd) faces nasdaq delisting risk over share price GuruFocus Mon, 21 Apr 2025 07:00:00 GMT
• affimed (afmd) faces nasdaq delisting risk due to low share pric GuruFocus Mon, 21 Apr 2025 07:00:00 GMT
• affimed gets nasdaq notice for non-compliance with $1 minimum bid price requirement Nasdaq Mon, 21 Apr 2025 07:00:00 GMT
• affimed (nasdaq:afmd) coverage initiated at stocknews.com Defense World Thu, 17 Apr 2025 08:36:05 GMT
• affimed n.v. receives eur 2.4 million research grant from german government to fund trispecific abs marketscreener.com Sun, 13 Apr 2025 21:10:10 GMT
• affimed (nasdaq:afmd) now covered by analysts at stocknews.com Defense World Wed, 09 Apr 2025 07:00:00 GMT
• affimed (nasdaq:afmd) receives $13.50 average target price from analysts Defense World Fri, 04 Apr 2025 07:00:00 GMT
• short interest in affimed (nasdaq:afmd) declines by 14.9% Defense World Tue, 01 Apr 2025 07:00:00 GMT
• affimed (nasdaq:afmd) coverage initiated at stocknews.com Defense World Tue, 01 Apr 2025 07:00:00 GMT
• Affimed Announces Acceptance of AFM24 Abstract on Dose GlobeNewswire Tue, 25 Mar 2025 07:00:00 GMT
• major cancer conference to showcase new afm24 drug optimization results for lung cancer treatment Stock Titan Tue, 25 Mar 2025 07:00:00 GMT
• affimed (afmd) to release quarterly earnings on thursday The AM Reporter Tue, 25 Mar 2025 07:00:00 GMT
• affimed at leerink’s conference: clinical and strategic insights Investing.com Tue, 11 Mar 2025 07:00:00 GMT
• fda armat status for affimed and artiva’s lymphoma combo therapy MSN Thu, 06 Mar 2025 23:22:23 GMT
• affimed to present at the leerink partners global healthcare conference 2025 Yahoo Finance Mon, 03 Mar 2025 08:00:00 GMT
• can affimed's ceo presentation signal new oncology breakthroughs? conference watch Stock Titan Mon, 03 Mar 2025 08:00:00 GMT
• short interest in affimed (nasdaq:afmd) declines by 12.3% Defense World Fri, 31 Jan 2025 08:08:11 GMT
• affimed (nasdaq:afmd) stock passes below two hundred day moving average – here’s why Defense World Thu, 30 Jan 2025 08:00:00 GMT
• jane street group llc acquires new position in affimed (nasdaq:afmd) Defense World Thu, 16 Jan 2025 08:00:00 GMT
• fda armat status for affimed and artiva’s lymphoma combo therapy MSN Sun, 12 Jan 2025 10:58:06 GMT
• affimed (nasdaq:afmd) sees large increase in short interest Defense World Sat, 28 Dec 2024 06:29:14 GMT
• hc wainwright issues positive forecast for affimed earnings Defense World Mon, 23 Dec 2024 08:00:00 GMT
• equities analysts offer predictions for affimed q1 earnings Defense World Sat, 21 Dec 2024 08:00:00 GMT
• nk cell therapy pipeline 2024: clinical trials assessment, fda approvals, therapies, and key companies involved by delveinsight | ... Barchart Fri, 20 Dec 2024 14:01:03 GMT
• analyst revises affimed therapeutics stock price target amid afm24 trial progression Investing.com Nigeria Wed, 18 Dec 2024 19:58:52 GMT
• affimed (nasdaq:afmd) given average rating of “moderate buy” by analysts Defense World Tue, 17 Dec 2024 20:04:21 GMT
• Affimed’s early lung cancer data disappoint; Indapta’s $22M round Endpoints News Tue, 17 Dec 2024 08:00:00 GMT
• affimed reports positive clinical update on afm24/atezolizumab combination therapy in non-small cell lung cancer (nsclc) GlobeNewswire Tue, 17 Dec 2024 08:00:00 GMT
• truist maintains buy on affimed, holds stock target amid trial update Investing.com Canada Tue, 17 Dec 2024 08:00:00 GMT
• affimed stock plunges 23% on afm24 study update (afmd:nasdaq) Seeking Alpha Tue, 17 Dec 2024 08:00:00 GMT
• affimed's afm24 trial shows promising 24% response rate in egfr-mutant lung cancer patients StockTitan Tue, 17 Dec 2024 08:00:00 GMT
• affimed’s afm24/atezolizumab combination shows positive results in nsclc trial TipRanks Tue, 17 Dec 2024 08:00:00 GMT
• affimed says 86% of patients responded to lymphoma therapy in mid-stage trial MSN Tue, 17 Dec 2024 02:09:13 GMT
• wells fargo & company lowers affimed (nasdaq:afmd) price target to $15.00 Defense World Sat, 14 Dec 2024 09:34:06 GMT
• affimed price target lowered to $15 from $20 at wells fargo TipRanks Thu, 12 Dec 2024 08:00:00 GMT
• affimed reports promising phase 1 efficacy and safety data for afm28 in relapsed/refractory acute myeloid leukemia (r/r aml) The Manila Times Tue, 10 Dec 2024 08:00:00 GMT
• Affimed Reports Promising Phase 1 Efficacy and Safety Data GlobeNewswire Mon, 09 Dec 2024 08:00:00 GMT
• affimed to host investor conference call highlighting clinical data from afm24 in combination with atezolizumab in non-small cell ... GlobeNewswire Mon, 09 Dec 2024 08:00:00 GMT
• affimed to present afm24 lung cancer clinical data in conference call StockTitan Mon, 09 Dec 2024 08:00:00 GMT
• affimed's afm28 shows 40% complete remission rate in hard-to-treat leukemia trial StockTitan Mon, 09 Dec 2024 08:00:00 GMT
• affimed announces positive results demonstrating safety and efficacy of acimtamig and allonk® combination in relapsed/refractory c... GlobeNewswire Sun, 08 Dec 2024 08:00:00 GMT
• affimed's cancer drug achieves 86% response rate in advanced lymphoma clinical trial StockTitan Sun, 08 Dec 2024 08:00:00 GMT
• fda armat status for affimed and artiva’s lymphoma combo therapy MSN Sat, 07 Dec 2024 18:37:18 GMT
• FDA RMAT status for Affimed and Artiva’s lymphoma combo therapy Indian Pharma Post Sat, 07 Dec 2024 08:00:00 GMT
• affimed announces pricing of upsized $90 million public offering of common shares StockTitan Fri, 06 Dec 2024 18:02:38 GMT
• fda armat status for affimed and artiva’s lymphoma combo therapy Yahoo Finance Fri, 06 Dec 2024 09:26:12 GMT
• AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy Yahoo Finance Fri, 06 Dec 2024 08:00:00 GMT
• fda grants rmat to affimed and artiva’s lymphoma therapy Pharmaceutical Technology Fri, 06 Dec 2024 08:00:00 GMT
• fda rmat status for affimed and artiva’s lymphoma combo therapy Yahoo Finance Fri, 06 Dec 2024 08:00:00 GMT
• affimed announces acimtamig and allonk® combination granted GlobeNewswire Thu, 05 Dec 2024 08:00:00 GMT
• affimed's cancer therapy wins fda rmat status after striking 83% response rate in lymphoma trial StockTitan Thu, 05 Dec 2024 08:00:00 GMT
• cantor fitzgerald reiterates "overweight" rating for affimed (nasdaq:afmd) MarketBeat Tue, 19 Nov 2024 15:05:26 GMT
• Is Affimed N.V. (AFMD) the Best German Stock to Buy Now? Insider Monkey Tue, 19 Nov 2024 08:00:00 GMT
• affimed's (afmd) "overweight" rating reiterated at cantor fitzgerald MarketBeat Tue, 19 Nov 2024 08:00:00 GMT
• stifel nicolaus lowers affimed (nasdaq:afmd) price target to $4.00 Defense World Sun, 17 Nov 2024 08:00:00 GMT
• affimed n.v. reports earnings results for the third quarter and nine months ended september 30, 2024 Marketscreener.com Fri, 15 Nov 2024 14:50:56 GMT
• stifel nicolaus cuts affimed (nasdaq:afmd) price target to $4.00 MarketBeat Fri, 15 Nov 2024 14:40:57 GMT
• earnings call: affimed reports promising results and strategic focus Investing.com Fri, 15 Nov 2024 14:16:51 GMT
• hc wainwright reiterates buy rating for affimed (nasdaq:afmd) MarketBeat Fri, 15 Nov 2024 13:13:48 GMT
• affimed nv (afmd) q3 2024 earnings call highlights: navigating financial challenges with ... Yahoo Finance Fri, 15 Nov 2024 08:00:00 GMT
• affimed n.v. (nasdaq:afmd) q3 2024 earnings call transcript Insider Monkey Fri, 15 Nov 2024 08:00:00 GMT
• stifel nicolaus lowers affimed (nasdaq:afmd) price target to $4.00 MarketBeat Fri, 15 Nov 2024 08:00:00 GMT
• affimed reports third quarter 2024 financial results & business update The Manila Times Thu, 14 Nov 2024 08:00:00 GMT
• affimed nv (afmd) q3 2024 earnings call highlights: navigating financial challenges with ... Yahoo Finance Thu, 14 Nov 2024 08:00:00 GMT
• affimed q3 revenue drops 90%, but net loss narrows as r&d costs decline | afmd stock news StockTitan Thu, 14 Nov 2024 08:00:00 GMT
• affimed n.v.: q3 earnings snapshot | national business news | voiceofalexandria.com Voice Of Alexandria Thu, 14 Nov 2024 08:00:00 GMT
• affimed nv earnings missed by €0.09, revenue fell short of estimates Investing.com Thu, 14 Nov 2024 08:00:00 GMT
• affimed (afmd) scheduled to post quarterly earnings on thursday Defense World Wed, 13 Nov 2024 07:47:01 GMT
• affimed to report third quarter 2024 financial results and corporate update on november 14, 2024 Marketscreener.com Thu, 07 Nov 2024 15:44:18 GMT
• affimed (nasdaq:afmd) share price passes above fifty day moving average - time to sell? MarketBeat Wed, 06 Nov 2024 10:48:19 GMT
• affimed to report third quarter 2024 financial results & corporate update on november 14, 2024 Yahoo Finance Wed, 06 Nov 2024 08:00:00 GMT
• affimed (afmd) sets q3 2024 earnings call for nov 14: immuno-oncology updates ahead StockTitan Wed, 06 Nov 2024 08:00:00 GMT
• affimed (nasdaq:afmd) share price passes above 50-day moving average - what's next? MarketBeat Wed, 06 Nov 2024 08:00:00 GMT
• affimed n.v. announces acceptance of three abstracts at the 2024 ash annual meeting including an oral presentation underscoring ad... Marketscreener.com Tue, 05 Nov 2024 15:14:35 GMT
• affimed announces acceptance of three abstracts at the 2024 GlobeNewswire Tue, 05 Nov 2024 08:00:00 GMT
• affimed to present promising aml treatment data at ash 2024 annual meeting StockTitan Tue, 05 Nov 2024 08:00:00 GMT
• affimed (nasdaq:afmd) receives consensus rating of "buy" from brokerages MarketBeat Mon, 28 Oct 2024 07:00:00 GMT
• affimed (nasdaq:afmd) given average rating of “buy” by analysts Defense World Mon, 28 Oct 2024 06:47:21 GMT
• 683 capital management, llc expands stake in affimed nv Yahoo Finance Thu, 24 Oct 2024 07:00:00 GMT
• exclusive: ex-affimed ceo heads to uk nanomedicine biotech; jami rubin leaves boundless bio after ipo Endpoints News Fri, 18 Oct 2024 07:00:00 GMT
• affimed n : annual general meeting results form 6 k Marketscreener.com Tue, 15 Oct 2024 11:01:08 GMT
• natural killer cell therapy market to witness robust expansion by 2032 | nektar therapeutics, innate pharma sa, affimed, chipscree... Cauverynews Thu, 10 Oct 2024 08:10:04 GMT
• analysts set affimed (nasdaq:afmd) target price at $20.00 MarketBeat Thu, 03 Oct 2024 07:00:00 GMT
• affimed (nasdaq:afmd) given average rating of "buy" by brokerages MarketBeat Thu, 03 Oct 2024 06:54:47 GMT
• strong early data in multiple indications supports buy rating for affimed therapeutics shares Investing.com Wed, 18 Sep 2024 01:52:31 GMT
• affimed (nasdaq:afmd) sees significant decrease in short interest MarketBeat Tue, 17 Sep 2024 17:52:25 GMT
• strong early data in multiple indications supports buy rating for affimed therapeutics shares Investing.com India Tue, 17 Sep 2024 07:00:00 GMT
• affimed (nasdaq:afmd) receives “overweight” rating from cantor fitzgerald Defense World Tue, 10 Sep 2024 07:41:30 GMT
• affimed to present at the cantor global healthcare conference 2024 Yahoo Finance Tue, 10 Sep 2024 07:00:00 GMT
• cantor fitzgerald reiterates "overweight" rating for affimed (nasdaq:afmd) MarketBeat Mon, 09 Sep 2024 17:54:55 GMT
• affimed (nasdaq:afmd) earns overweight rating from cantor fitzgerald MarketBeat Mon, 09 Sep 2024 17:54:55 GMT
• affimed (nasdaq:afmd) receives consensus rating of "buy" from analysts MarketBeat Sun, 08 Sep 2024 05:48:58 GMT
• affimed (nasdaq:afmd) receives average rating of "buy" from analysts MarketBeat Sun, 08 Sep 2024 05:48:58 GMT
• affimed n.v. (nasdaq:afmd) q2 2024 earnings call transcript Insider Monkey Sat, 07 Sep 2024 12:03:18 GMT
• hc wainwright reaffirms buy rating for affimed (nasdaq:afmd) MarketBeat Fri, 06 Sep 2024 17:44:22 GMT
• affimed's (afmd) "buy" rating reaffirmed at hc wainwright MarketBeat Fri, 06 Sep 2024 17:44:22 GMT
• Roche’s Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed Endpoints News Fri, 06 Sep 2024 07:00:00 GMT
• earnings call: affimed reports promising clinical results and stable finances Investing.com India Fri, 06 Sep 2024 07:00:00 GMT
• stifel holds affimed at $5 target with new ceo at helm Investing.com India Fri, 06 Sep 2024 07:00:00 GMT
• affimed nv (afmd) q2 2024 earnings call transcript highlights: f GuruFocus.com Fri, 06 Sep 2024 06:41:53 GMT
• affimed to present preclinical data demonstrating cytotoxic activity of its novel innate cell engager afm28 at the annual meeting ... Yahoo Finance UK Thu, 05 Sep 2024 23:11:00 GMT
• affimed appoints shawn m. leland as chief executive officer Yahoo Finance UK Thu, 05 Sep 2024 16:59:37 GMT
• affimed nv reports results for the quarter ended in june 30 - earnings summary XM Thu, 05 Sep 2024 13:43:40 GMT
• affimed reports second quarter 2024 financial results & business update GlobeNewswire Thu, 05 Sep 2024 07:00:00 GMT
• affimed n.v.: q2 earnings snapshot | national business news | voiceofalexandria.com Voice Of Alexandria Thu, 05 Sep 2024 07:00:00 GMT
• stifel holds affimed at $5 target with new ceo at helm Investing.com Thu, 05 Sep 2024 07:00:00 GMT
• affimed appoints new ceo, shares fall on leadership change Yahoo Finance Wed, 04 Sep 2024 07:00:00 GMT
• affimed follow up: upcoming acimtamig and afm24 updates could be positive catalysts Seeking Alpha Wed, 04 Sep 2024 07:00:00 GMT
• affimed nv (afmd) q2 2024 earnings report preview: what to look for GuruFocus.com Wed, 04 Sep 2024 07:00:00 GMT
• affimed names shawn leland as new ceo by investing.com Investing.com UK Tue, 03 Sep 2024 11:54:00 GMT
Affimed(NASDAQ:AFMD) 
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. Its lead product candidate is AFM13, a natural killer cell (NK-cell) TandAb, which has completed Phase 2a clinical study of relapsed CD30-...
Website: http://www.affimed.com
Founded: 2000
Full Time Employees: 137
Sector: Healthcare
Industry: Biotechnology